Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
ClinicalTrials.gov Identifier:
NCT01583686
First received: April 20, 2012
Last updated: December 13, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)